Mary Wilson
New member
The name of the vaccine was changed to Vaxzevria on 25 March 2021.
European Medicines Agency
26/03/2021
COVID-19 Vaccine (ChAdOx1-S [recombinant])
Table of contents
https://www.ema.europa.eu/en/medicin...ne-astrazeneca
__________________________________________________ __________________________
Vaxzevria1 (COVID-19 Vaccine (ChAdOx1-S [recombinant]))
An overview of Vaxzevria and why it is authorised in the EU
EMA/182334/2021 EMEA/H/C/005675
What is Vaxzevria and what is it used for?
Vaxzevria is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. COVID-19 is caused by SARS-CoV-2 virus.
Vaxzevria is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2.
Vaxzevria does not contain the virus itself and cannot cause COVID-19.
https://www.ema.europa.eu/en/documen...verview_en.pdf
European Medicines Agency
26/03/2021
COVID-19 Vaccine (ChAdOx1-S [recombinant])
Table of contents
https://www.ema.europa.eu/en/medicin...ne-astrazeneca
__________________________________________________ __________________________
Vaxzevria1 (COVID-19 Vaccine (ChAdOx1-S [recombinant]))
An overview of Vaxzevria and why it is authorised in the EU
EMA/182334/2021 EMEA/H/C/005675
What is Vaxzevria and what is it used for?
Vaxzevria is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. COVID-19 is caused by SARS-CoV-2 virus.
Vaxzevria is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2.
Vaxzevria does not contain the virus itself and cannot cause COVID-19.
https://www.ema.europa.eu/en/documen...verview_en.pdf
Last edited by a moderator: